Monday, October 11, 2021

Booming Biotech Stock Focuses On Fighting COVID-19 "Analyst" Predict 30X Upside

"All In" $.35 Stock Secures COVID-19 Vaccine

Rollout HUGE Upside

Fellow Investor,

I want to keep this short because the opportunity is moving fast...

This $.35 medical stock has recently secured the rights to distribute and sell the COVID-19 vaccines for Pfizer, Johnson & Johnson, Moderna and AstraZeneca. See for yourself here.

You will NOT get another chance like this in a long time, overlooking this is a very big mistake on your part.

These 3 Stocks Soared On Similar News

1. Novavax stock sky-rocketed 20% same day

2. Ocugen stock sky-rocketed 31% same day

3. Pfizer stock sky-rocketed 31.7% same day

Get in while you still can on the ground floor of this medical company here that distributes the COVID-19 vaccine, and diagnostic test kits as well

Additionally, several Wall Street analysts have a strong buy & price target predicting huge upside. See this here before the crowd jumps in.

This report right here will give you information about the company name, ticker symbol, and the full analyst report predicting huge upside.

Regards,

 

Jamie Rothstein

Editor In Chief, TradingCapitalist Investment Research

 

 




 

 
 
  This email was sent to edwardlorilla1986.paxforex@blogger.com by editor@marketmovingtrends.com

MarketMovingTrends, 45 South Park Place, #203, Morristown, NJ 07960 United States
 
 

No comments:

Post a Comment

Is Crocs’ Winning Streak Over?

Represent Sells Minority Stake; What Happened at Telfar's Store Opening; Black Friday Preview ADVERTISEMENT WHAT ...